共 50 条
- [41] An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic LymphohistiocytosisBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (11) : 1625 - 1631Marsh, Rebecca A.Kim, Mi-OkLiu, ChunyanBellman, DeniseHart, LauraGrimley, MichaelKumar, AshishJodele, SonataMyers, Kasiani C.Chandra, SharatLeemhuis, TomMehta, Parinda A.Bleesing, Jack J.Davies, Stella M.Jordan, Michael B.Filipovich, Alexandra H.
- [42] The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell TransplantationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S123 - S123Marsh, Rebecca A.Kim, Mi-OkLiu, ChunyanBellman, DeniseHart, LauraJordan, Michael B.Bleesing, JackMehta, Parinda A.Jodele, SonataMyers, KasianiKumar, AshishGrimley, MichaelDavies, StellaFilipovich, Lisa
- [43] Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning for Mixed Phenotype Acute Leukemia with Minimal Residual DiseasePEDIATRIC BLOOD & CANCER, 2021, 68Manabe, ShujiNakamura, SayakaToujyo, RyunosukeSaito, AtsuroKozaki, AikoIshida, ToshiakiKishimoto, KenjiMori, TakeshiHasegawa, DaiichiroKosaka, Yoshiyuki
- [44] Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD miceSTEM CELLS, 2008, 26 (02) : 381 - 386Verda, LarissaKim, Duck AnIkehara, SusumuStatkute, LaisvydeBronesky, DelphinePetrenko, YevgeniyaOyama, YuHe, XiangLink, CharlesVahanian, Nicholas N.Burt, Richard K.
- [45] Chimerism -: Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabineBONE MARROW TRANSPLANTATION, 2002, 29 (07) : 621 - 624Görner, MKordelas, LThalheimer, MLuft, TPfeiffer, SUstaoglu, FPunzel, MWeber-Nordt, RMoos, MGoldschmidt, HHo, AD
- [46] A partial conditioning strategy to achieve stable multilineage mixed chimerism in the rat: CD8+cells in the recipient microenvironment contribute to alloresistance to engraftment.BLOOD, 1999, 94 (10) : 320B - 320BHuang, YMMills, LAPrabhune, KAIldstad, ST
- [47] Successful induction of mixed chimerism and tolerance with non-myeloablative conditioning in mice presensitized with fully mismatched skin grafts.CLINICAL IMMUNOLOGY, 2005, 115 : S25 - S26Bardwell, PDShimizu, IBuchli, JCSykes, M
- [48] Nonlethal conditioning to achieve stable mixed chimerism in the rat: Treatment of recipients with ALS and tacrolimus substantially reduces the dose of radiation sufficient for donor engraftment.BLOOD, 1996, 88 (10) : 2394 - 2394Gammie, JSIldstad, STLi, SKawaharada, NColson, YLKaufman, CLPham, SM
- [49] Interleukin-9 (IL-9) reduces T cell-mediated insulitis in autoimmune prone nonobese diabetic (NOD) mice.DIABETOLOGIA, 1998, 41 : A161 - A161Many, MCColin, IMAu, DDenef, JFRenauld, JC
- [50] Development of a Clinically Relevant Conditioning Regimen Using Available Costimulatory Blockade Reagents for Induction of Renal Allograft Tolerance Via Mixed Hematopoietic ChimerismAMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 104 - 104Yamada, Y.Lee, S.Boskovic, S.Nadazdin, O.Smith, R.Colvin, R.Madsen, J.Sachs, D.Benichou, G.Cosimi, B.Kawai, T.